Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways

Autor: Annie J. Zalon, Li Zeng, Henry L. Paulson, Dapeng Zhang, L. Aravind, Hayley S. McLoughlin
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
Transcription
Genetic

Microarrays
Gene Expression
lcsh:Medicine
Biochemistry
Histones
Gene Knockout Techniques
Mice
0302 clinical medicine
Cell Signaling
Transcriptional regulation
Ataxin-3
Promoter Regions
Genetic

lcsh:Science
WNT Signaling Cascade
Regulation of gene expression
Multidisciplinary
Transcriptional Control
Wnt signaling pathway
Acetylation
Signaling Cascades
Ephrin-A3
Cell biology
Bioassays and Physiological Analysis
Knockout mouse
Spinocerebellar ataxia
Female
Signal transduction
Signal Transduction
Research Article
Biology
Research and Analysis Methods
Histone Deacetylases
Cell Line
03 medical and health sciences
EPH receptor A3
Gene Types
DNA-binding proteins
Genetics
medicine
Animals
Ephrin
Gene Regulation
lcsh:R
Biology and Life Sciences
Proteins
Cell Biology
medicine.disease
030104 developmental biology
Gene Expression Regulation
TGF-beta signaling cascade
Regulator Genes
lcsh:Q
030217 neurology & neurosurgery
Zdroj: PLoS ONE, Vol 13, Iss 9, p e0204438 (2018)
PLoS ONE
ISSN: 1932-6203
Popis: Spinocerebellar ataxia type 3 (SCA3) is a dominantly inherited neurodegenerative disorder caused by a polyglutamine-encoding CAG repeat expansion in the ATXN3 gene which encodes the deubiquitinating enzyme, ATXN3. Several mechanisms have been proposed to explain the pathogenic role of mutant, polyQ-expanded ATXN3 in SCA3 including disease protein aggregation, impairment of ubiquitin-proteasomal degradation and transcriptional dysregulation. A better understanding of the normal functions of this protein may shed light on SCA3 disease pathogenesis. To assess the potential normal role of ATXN3 in regulating gene expression, we compared transcriptional profiles in WT versus Atxn3 null mouse embryonic fibroblasts. Differentially expressed genes in the absence of ATXN3 contribute to multiple signal transduction pathways, suggesting a status switch of signaling pathways including depressed Wnt and BMP4 pathways and elevated growth factor pathways such as Prolactin, TGF-β, and Ephrin pathways. The Eph receptor A3 (Efna3), a receptor protein-tyrosine kinase in the Ephrin pathway that is highly expressed in the nervous system, was the most differentially upregulated gene in Atxn3 null MEFs. This increased expression of Efna3 was recapitulated in Atxn3 knockout mouse brainstem, a selectively vulnerable brain region in SCA3. Overexpression of normal or expanded ATXN3 was sufficient to repress Efna3 expression, supporting a role for ATXN3 in regulating Ephrin signaling. We further show that, in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR in ATXN3 null cells. Together, these results reveal a normal role for ATXN3 in transcriptional regulation of multiple signaling pathways of potential relevance to disease processes in SCA3.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje